This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB04248/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04248/identifier/pubchem-compound/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04248/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04248/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04248
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04248 n7:DB04248
dcterms:title
Beta-1,4-Galactotrioside
adms:identifier
n10:46936192 n11:46508813 n12:DB04248 n13:B4G
n3:IUPAC-Name
n4:271B4834-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B483A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4839-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4836-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4837-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4838-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4832-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4830-363D-11E5-9242-09173F13E4C5 n4:271B4833-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4831-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4840-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4841-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B483B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B483C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B483E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B483D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B483F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4846-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4848-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4849-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4845-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4844-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4847-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4835-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4842-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4843-363D-11E5-9242-09173F13E4C5